Schalken, J. A., A. J. Roebroek, et al. (1987) . "fur gene expression as a discriminating marker for small cell and nonsma ll cell lung carcinomas." J Clin Invest 80(6): 1545-9. 182. Senzer N, B. M., Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J (2012). "Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG™ ) in Advanced Cancer." Molecular Therapy 20(3): 7. 183. Senzer N, B. M., Nemunaitis J, Kuhn J, Melnyk A, Beitsch P, Magee M, Oh J, Bedell C, Kumar P, Rao D, Pappen B, Wallraven G, Brunicardi F, Maples P, Nemunaitis J (2013). "Long Term Follow Up: Phase I Trial of “bi-shRNA furin/GMCSF DNA/Autologous Tumor Cell” Immunotherapy (FANG™) in Advanced Cancer." Journal of Vaccines and Vaccination. Protocol # CL-PTL 105 CONFIDENTIAL AM #9 09/25/15 Page 92 184. Senzer, N., H. Kaufman, T. Amatruda, M. Nemunaitis, G. Daniels, J. Glaspy, H. Goldsweig, R. S. Coffin, J. Nemunaitis, The OncoVEX Melanoma Phase II Investigator Group; MCMRC, Dallas, TX ; Columbia University, New York, NY; Hubert H. Humphrey Cancer Center, Minneapolis, MN; UCSD, San Diego, CA; UCLA, Los Angeles, CA; BioV ex, Inc., Woburn, MA (2009). "Phase II clinical trial with a second generation, GM-CSF encoding, oncolytic herpesvirus in unresectable metastatic melanoma." J Clin Oncol 27(15s). 185. Shen, Z., G. Reznikoff, et al. (1997) . "Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules." J Immunol 158(6): 2723-30. 186.